Zmax

Urethritis, Chancroid, Tonsillitis + 34 more

Treatment

27 FDA approvals

17 Active Studies for Zmax

Treatment for

Urethritis

What is Zmax

AzithromycinThe Generic name of this drug

Treatment SummaryAzithromycin is an antibiotic used to treat a wide range of infections, such as respiratory, enteric and genitourinary infections. It is related to erythromycin, but has a different chemical structure. Azithromycin was approved by the FDA in 1991. In March 2020, a small study conducted in France showed positive results when azithromycin was combined with an anti-malaria drug to treat COVID-19. However, more research is needed to confirm these results.

Zithromaxis the brand name

Zmax Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Zithromax

Azithromycin

1994

541

Approved as Treatment by the FDA

Azithromycin, otherwise called Zithromax, is approved by the FDA for 27 uses including Mycoplasma pneumoniae infection and genital ulcers caused by haemophilus ducreyi infection .

Mycoplasma pneumoniae infection

genital ulcers caused by haemophilus ducreyi infection

Communicable Diseases

Streptococcus Agalactiae Infection

Staphylococcus (S.) Aureus Infection

Haemophilus ducreyi infection

Genus Chlamydia

Tonsillitis

Sore Throat

Genital Ulcer Disease (GUD)

Haemophilus Influenzae Infections

Adult Patients

Pneumococcal Infections

Community Acquired Pneumonia (CAP)

Acute Otitis Media (AOM)

ABDIC protocol

patients appropriate for oral therapy

Adults

Moraxella Catarrhalis Infection

Tonsillitis

Pediatric Patients

Moraxella catarrhalis

Sinusitis

Streptococcus pyogenes

Streptococcal Pharyngitis

Streptococcus pyogenes

unable to prescribe first line therapy for streptococcus pyogenes tonsillitis

Effectiveness

How Zmax Affects PatientsMacrolides are a type of drug used to treat bacterial infections. They work by blocking the production of proteins that the bacteria need to survive. Azithromycin has additional benefits and is often used to help with chronic respiratory diseases.

How Zmax works in the bodyAzithromycin is an antibiotic that works by preventing bacteria from producing proteins. It binds to the ribosomes of the bacterial cells, blocking their ability to create proteins that are necessary for them to survive and reproduce. This stops the spread of bacterial infections. Azithromycin is more effective than other antibiotics because it is more stable in low pH levels, so it stays in the body longer and can reach higher concentrations in tissues.

When to interrupt dosage

The suggested amount of Zmax is predicated on the diagnosed affliction, including Streptococcus Agalactiae Infection, Chlamydia trachomatis and Genus Chlamydia. The dosage is subject to the technique of delivery depicted in the table underneath.

Condition

Dosage

Administration

Cervicitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Tonsillitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

unable to prescribe first line therapy for streptococcus pyogenes tonsillitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Streptococcus pyogenes

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Moraxella catarrhalis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Streptococcus Agalactiae Infection

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Acute Otitis Media (AOM)

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Moraxella Catarrhalis Infection

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Genus Chlamydia

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Chancroid

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Urethritis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Bacterial conjunctivitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Adult Patients

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

genital ulcers caused by haemophilus ducreyi infection

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Mycoplasma pneumoniae infection

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Pediatric Patients

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Sore Throat

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Communicable Diseases

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Pelvic Inflammatory Disease (PID)

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Pneumococcal Infections

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Warnings

Zmax Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

cholestatic jaundice

Do Not Combine

prior azithromycin use

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

There are 20 known major drug interactions with Zmax.

Common Zmax Drug Interactions

Drug Name

Risk Level

Description

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Anagrelide.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Arsenic trioxide.

Artemether

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Artemether.

Asenapine

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Asenapine.

Astemizole

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Astemizole.

Zmax Toxicity & Overdose RiskThe lethal dose of azithromycin for rats is greater than 2000mg/kg. Side effects may include heart problems, hearing loss, and liver or kidney damage. People with reduced liver function should be careful when taking azithromycin. Pregnant women should only take azithromycin if it is absolutely necessary, as it is unknown if the drug is passed to babies through milk. Long-term studies have not been done to determine if the drug causes cancer, but so far it has not been found to be mutagenic or to affect fertility.

image of a doctor in a lab doing drug, clinical research

Zmax Novel Uses: Which Conditions Have a Clinical Trial Featuring Zmax?

Currently, 9 active clinical trials are underway to assess the utility of Zmax in treating Moraxella Catarrhalis Infection, Staphylococcus (S.) Aureus Infection and Communicable Diseases.

Condition

Clinical Trials

Trial Phases

Cervicitis

1 Actively Recruiting

Not Applicable

Communicable Diseases

2 Actively Recruiting

Phase 2, Not Applicable

Bacterial Conjunctivitis

0 Actively Recruiting

Community Acquired Pneumonia (CAP)

1 Actively Recruiting

Not Applicable

Communicable Diseases

0 Actively Recruiting

Diarrhea

0 Actively Recruiting

Adult Patients

0 Actively Recruiting

Haemophilus ducreyi infection

0 Actively Recruiting

Staphylococcus (S.) Aureus Infection

2 Actively Recruiting

Phase 4, Phase 1

Acute Otitis Media (AOM)

3 Actively Recruiting

Not Applicable

Bacterial conjunctivitis

0 Actively Recruiting

ABDIC protocol

0 Actively Recruiting

Haemophilus Influenzae Infections

0 Actively Recruiting

Chancroid

0 Actively Recruiting

Streptococcus pyogenes

0 Actively Recruiting

Pediatric Patients

1 Actively Recruiting

Phase 2

Genus Chlamydia

0 Actively Recruiting

unable to prescribe first line therapy for streptococcus pyogenes tonsillitis

0 Actively Recruiting

Moraxella catarrhalis

0 Actively Recruiting

Sore Throat

4 Actively Recruiting

Not Applicable

Zmax Reviews: What are patients saying about Zmax?

5Patient Review

1/5/2011

Zmax for Acute Bacterial Infection of the Sinuses

About an hour after taking this medication, I experienced diarrhea. This happened a few times throughout the night. Additionally, I had mild stomach cramps but nothing too severe. My mouth was also very dry; however, this could be due to the fact that I couldn't really breathe through my nose. The next day, I still experienced loose stool but no other symptoms.

5Patient Review

3/25/2010

Zmax for Acute Bacterial Infection of the Sinuses

I only needed two days worth of this medication and I'm feeling almost back to normal. The slight dizziness is a manageable side effect.

4.7Patient Review

3/19/2008

Zmax for Acute Bacterial Infection of the Sinuses

I experienced quite a bit of stomach pain and nausea while taking this medication.

4.7Patient Review

9/17/2009

Zmax for Severe Sinusitis caused by Streptococcus Pneumoniae

Though it took a bit longer than I would've liked, this fever reducer really knocked out my fever quickly and effectively.

4.3Patient Review

1/30/2011

Zmax for Acute Bacterial Infection of the Sinuses

I took the recommended oral dose yesterday with no issues, but I'm feeling pretty dizzy today.

4.3Patient Review

3/30/2008

Zmax for Pneumonia caused by Bacteria

I liked that I only had to take this medication once, but unfortunately it made me feel very nauseous and gave me a headache (and some dizziness).

4Patient Review

6/6/2008

Zmax for Acute Bacterial Infection of the Sinuses

I found this treatment really effective. I was a little bit dizzy but it wasn't anything serious. It's great to have something that works so quickly.

4Patient Review

10/9/2011

Zmax for Acute Bacterial Infection of the Sinuses

I've been taking this for two days now to help with a sinus infection. The infection itself seems to be getting better, but I have experienced some serious gastrointestinal side effects, including vomiting and diarrhea. Additionally, I have felt mildly dizzy and lost my appetite.

4Patient Review

11/5/2008

Zmax for Pneumonia caused by the Bacteria Chlamydia

I had a lot of stomach pain while taking this, but it eventually went away. It was nice only having to take it once, and it worked just as well as the z-pack.

3Patient Review

12/1/2010

Zmax for Pneumonia caused by Bacteria

I followed the instructions to take the oral dose on an empty stomach, but I ended up vomiting uncontrollably for over an hour. It was so bad that I lost consciousness briefly. Three weeks later and pneumonia is much better, however, I've developed terrible side effects from the medication like persistent diarrhea, bloating, cramping, and blood in my stool. Do not recommend this medicine because of these harmful side effects!

3Patient Review

12/15/2012

Zmax for Acute Bacterial Infection of the Sinuses

I started noticing negative effects after taking the last of my doctor-prescribed 10 tablets of 500mg each. I've been dealing with diarrhea, vomiting and nausea for the past four months now. Is there any relief?

3Patient Review

11/13/2010

Zmax for Pneumonia caused by Bacteria

I threw up around an hour and a half after taking this medication, and then continued to vomit for another four hours. I followed the instructions by taking it on an empty stomach, but afterwards I felt much better.

2Patient Review

11/10/2008

Zmax for Acute Bacterial Infection of the Sinuses

Unfortunately, this medication gave me severe stomach cramps and diarrhea. Additionally, after taking it for a few days, my sinus symptoms came back.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about zmax

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can you use zMAX in diesel?

"Yes, zMAX can be used in both gasoline and diesel engines."

Answered by AI

What does zMAX do for your engine?

"It doesn't matter what year your vehicle is, it needs zMAX Micro-lubricant to disperse carbon build-up in your engine, fuel system and transmission. This helps improve performance, extend engine life and reduce emissions."

Answered by AI

Is there a zMAX?

"zMAX is a micro-lubricant that uses the fluids in your vehicle to get to internal parts where it soaks into metal to disperse harmful carbon build-up. Other products change the viscosity of the oil. zMAX doesn't need to do that. It works all on its own."

Answered by AI

Clinical Trials for Zmax

Image of Harris Health System in Houston, United States.

Extra-Virgin Coconut Oil for Breastfeeding

This trial aims to compare the effectiveness of using extra-virgin coconut oil versus Highly Purified Anhydrous (HPA) Lanolin in reducing nipple pain, cracking, and preventing subacute

Waitlist Available

Harris Health System

Image of Queen Elizabeth II Health Sciences Centre in Halifax, Canada.

Chlamydia trachomatis and Neisseria gonorrhea self-swab(s) and/or urine collection for Gonorrhea

Halifax, Canada

This trial aims to test a new project in Nova Scotia where pharmacists will help manage and treat Chlamydia and Gonorrhea infections. These infections are becoming more common in Canada, but many

Waitlist Available

Queen Elizabeth II Health Sciences Centre

Image of Whiteriver Center for Indigenous Health in Whiteriver, United States.

Education + Household supplies for Staph Infection

This trial aims to find a way to reduce the spread of Staphylococcus aureus (SA) infections among Indigenous people. Participants will be divided into two groups - one group will receive education

Waitlist Available

Whiteriver Center for Indigenous HealthLaura Hammitt, MD

Image of Butler Hospital in Providence, United States.

Alpha-Stim AID cranial electrotherapy stimulation for Adult

This trial is testing if firefighters can use a device called cranial electrotherapy stimulation (CES) at home. The trial also wants to see if using CES can help reduce stress in firefighters. The trial

Waitlist Available

Butler HospitalMascha van 't Wout-Frank, PhD

Have you considered Zmax clinical trials? We made a collection of clinical trials featuring Zmax, we think they might fit your search criteria.

Explore trials for Zmax

Image of University of Alberta in Edmonton, Canada.

Educational Blogshots for Parenting Health Decisions

Edmonton, Canada

This trial will help determine if blogshots (images summarizing info) are useful for parents to make better healthcare choices for their kids.

Waitlist Available

University of AlbertaLisa Hartling, PhD

Image of Rush University Medical Center in Chicago, United States.

Menstrual Cups for Vaginal Infections

This trial aims to reduce bacterial vaginosis and STIs in Kenyan women at high risk of HIV with the use of menstrual cups. It will also measure the safety & impact of menstrual cups on vaginal microbiome.

Rush University Medical Center

Image of Avon Hospital in Avon, United States.

Targeted Antibiotic Therapy for Pneumonia

This trial will test if reducing exposure to broad-spectrum antibiotics can help detect & reduce infections faster.

Avon Hospital (+11 Sites)Michael Rothberg, M.D.

Image of Massachusetts General Hospital in Boston, United States.

Rapid Diagnostic Assay for Gonorrhea

This trial will test two methods of rapid diagnosis for urethritis & cervicitis in a clinic setting. 100 patients will be tested to compare the methods.

Massachusetts General HospitalIngrid V. Bassett, MD, MPH

Have you considered Zmax clinical trials? We made a collection of clinical trials featuring Zmax, we think they might fit your search criteria.

Explore trials for Zmax

Image of AVANCE-Houston in Houston, United States.

Intervention 1: AVANCE-Houston FRAMEWorks Program Weekly Workshops Spread Across 7 Weeks (spaced out format) for Adult

This trial is testing two different schedules for a course that teaches skills for healthy families, to see which one leads to better retention of the skills and improved outcomes.

AVANCE-HoustonMatt D Shepherd, PhDAvance Clinical Pty Ltd.

Image of Pediatric Associates in Plantation, United States.

Outpatient Stewardship Program for Antibiotic Overuse in Pediatric Infections

This trialwill examine how to reduce unnecessary antibiotics in pediatric settings to improve health and prevent resistance.

Waitlist Available

Pediatric Associates (+4 Sites)Jeffrey Gerber, MD PhD MSCE

Image of Rochester General Hospital in Rochester, United States.

Immune Response Monitoring for Ear Infection

This trial will examine the changes in the types of bacteria present in the nose and their effect on ear infections over time.

Waitlist Available

Rochester General HospitalMichael Pichichero, MD

Image of St. Luke's Health System in Boise, United States.

Suicide Prevention Interventions for Suicide Prevention

This trial will compare the effectiveness of two brief suicide prevention interventions in reducing suicidal ideation and behavior, and increasing uptake of outpatient mental healthcare services, over 12 months.

Waitlist Available

St. Luke's Health SystemAnna K Radin, DrPH, MPH

Have you considered Zmax clinical trials? We made a collection of clinical trials featuring Zmax, we think they might fit your search criteria.

Explore trials for Zmax

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security